Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity

Experimental Animals

Volumn 59, Issue 5, 2010, Pages 595-604

  Ha, Seung Kwon ^a   Chae, Chanhee ^a  

^a Seoul National University   (South Korea)

Author keywords

C57BL 6 mouse; High fat diet; iNOS; Non alcoholic steatohepatitis; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY FAT; BODY WEIGHT; C57BL 6 MOUSE; CENTRAL VEIN; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LIPID DIET; LIVER CELL; LIVER INJURY; LIVER WEIGHT; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ORGAN WEIGHT; PANCREAS; PANCREAS INJURY; PATHOGENESIS;

ADIPOSE TISSUE; ANIMALS; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; DIETARY FATS; FATTY LIVER; GLUCOSE TOLERANCE TEST; IMAGE PROCESSING, COMPUTER-ASSISTED; INSULIN; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; ORGAN SIZE; PANCREAS;

ANIMALIA; MUS;

EID: 78149418436     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.59.595     Document Type: Article

References (44)

1. Adams, L.A., Angulo, P., and Lindor, K.D. 2005. Nonalcoholic fatty liver disease. CMAJ 172: 899-905.
2. Ahren, B. and Scheurink, A.J. 1998. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur. J. Endocrinol. 139: 461-467.
3. Anstee, Q.M. and Goldin, R.D. 2006. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87: 1-16.
4. Breslow, J. 1996. Mouse models of atherosclerosis. Science 272: 685.
5. Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., and Shoelson, S.E. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11: 183-190.
6. Chen, S., Chen, Y., Shi, J., Lin, Y., and Xie, W. 2006. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig. Dis. Sci. 51: 2225-2234.
7. Cho, W.S. and Chae, C. 2002. Immunohistochemical detection and distribution of inducible nitric oxide synthase in pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol. 126: 109-114.
8. Collins, S., Martin, T.L., Surwit, R.S., and Robidoux, J. 2004. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 81: 243-248.
9. Comuzzie, A.G. and Allison, D.B. 1998. The search for human obesity genes. Science 280: 1374-1377.
10. Day, C. and James, O. 1998. Hepatic steatosis: innocent bystander or guilty party? Hepatology (Baltimore, Md.) 27: 1463.
11. Escola-Gil, J.C., Jorba, O., Julve-Gil, J., Gonzalez-Sastre, F., Ordonez-Llanos, J., and Blanco-Vaca, F. 1999. Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis. Clin. Chem. 45: 1567-1569.
12. Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J.A., Ueki, K., and Kaneki, M. 2005. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54: 1340-1348.
13. Garcia-Monzon, C., Majano, P.L., Zubia, I., Sanz, P., Apolinario, A., and Moreno-Otero, R. 2000. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J. Hepatol. 32: 331-338.
14. Garcia-Monzon, C., Martin-Perez, E., Iacono, O., Fernandez-Bermejo, M., Majano, P., Apolinario, A., Larranaga, E., and Moreno-Otero, R. 2000. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J. Hepatol. 33: 716-724.
15. James, P.T., Leach, R., Kalamara, E., and Shayeghi, M. 2001. The worldwide obesity epidemic. Obes. Res. 9: 228S-233S.
16. Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S.E., Rogers, T., Lucia, M.S., Li, J., and Levi, M. 2005. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 280: 32317-32325.
17. Jiao, S., Cole, T., Kitchens, R., Pfleger, B., and Schonfeld, G. 1990. Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors. J. Lipid Res. 31: 467.
18. Karlsson, M., Marild, S., Brandberg, J., Lonn, L., Friberg, P., and Strandvik, B. 2006. Serum phospholipids fatty acids, adipose tissue, and metabolic markers in obese adolescents&ast. Obesity 14: 1931-1939.
19. Larter, C.Z. and Farrell, G.C. 2006. Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J. Hepatol. 44: 253-261.
20. Letteron, P., Fromenty, B., Terris, B., Degott, C., and Pessayre, D. 1996. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 24: 200-208.
21. Loeb, W.F. and Quimby, F.W. 1989. The Clinical Chemistry of Laboratory Animals, Pergamon, New York.
22. Majano, P.L., Garcia-Monzon, C., Lopez-Cabrera, M., Lara-Pezzi, E., Fernandez-Ruiz, E., Garcia-Iglesias, C., Borque, M.J., and Moreno-Otero, R. 1998. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J. Clin. Invest. 101: 1343-1352.
23. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., and Rizzetto, M. 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923.
24. Matteoni, C., Younossi, Z., Gramlich, T., Boparai, N., Liu, Y., and McCullough, A. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419.
25. McCullough, A. 2004. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 521-533.
26. Mokdad, A.H., Ford, E.S., Bowman, B.A., Dietz, W.H., Vinicor, F., Bales, V.S., and Marks, J.S. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79.
27. Nouchi, T., Worner, T., Sato, S., and Lieber, C. 1987. Serum procollagen type III N-terminal peptides and laminin P 1 peptide in alcoholic liver disease. Alcohol. Clin. Exp. Res. 11: 287-291.
28. Oddis, C.V. and Finkel, M.S. 1996. NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am. J. Physiol. 270: H1864-1868.
29. Paigen, B., Plump, A., and Rubin, E. 1994. The mouse as a model for human cardiovascular disease and hyperlipidemia. Curr. Opin. Lipidol. 5: 258.
30. Petersen, K.F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D.L., DiPietro, L., Cline, G.W., and Shulman, G.I. 2003. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142.
31. Powell, E.E., Cooksley, W.G., Hanson, R., Searle, J., Halliday, J.W., and Powell, L.W. 1990. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74-80.
32. Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., and Poynard, T. 2000. Liver fibrosis in overweight patients. Gastroenterology 118: 1117-1123.
33. Sanyal, A.J. 2002. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725.
34. Shimomura, I., Bashmakov, Y., and Horton, J.D. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274: 30028-30032.
35. Smith, B.K., Andrews, P.K., and West, D.B. 2000. Macronutrient diet selection in thirteen mouse strains. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: R797-805.
36. Sone, H. and Kagawa, Y. 2005. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48: 58-67.
37. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
38. Surwit, R.S., Kuhn, C.M., Cochrane, C., McCubbin, J.A., and Feinglos, M.N. 1988. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37: 1163-1167.
39. Toye, A.A., Lippiat, J.D., Proks, P., Shimomura, K., Bentley, L., Hugill, A., Mijat, V., Goldsworthy, M., Moir, L., Haynes, A., Quarterman, J., Freeman, H.C., Ashcroft, F.M., and Cox, R.D. 2005. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48: 675-686.
40. West, D.B., Boozer, C.N., Moody, D.L., and Atkinson, R.L. 1992. Dietary obesity in nine inbred mouse strains. Am. J. Physiol. 262: R1025-1032.
41. Winzell, M.S. and Ahren, B. 2004. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53: S215-219.
42. Yamakawa, T., Tanaka, S., Yamakawa, Y., Kiuchi, Y., Isoda, F., Kawamoto, S., Okuda, K., and Sekihara, H. 1995. Augmented production of tumor necrosis factor-alpha in obese mice. Clin. Immunol. Immunopathol. 75: 51-56.
43. Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., and Diehl, A.M. 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94: 2557-2562.
44. Yu, Y.H. and Ginsberg, H.N. 2005. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ. Res. 96: 1042-1052.